Texas Halo Fund

Founded in 2012, Texas Halo Fund is a venture capital firm headquartered in Houston, Texas. It specializes in investing in early-stage companies across various sectors, focusing on businesses with promising growth prospects and strong management teams.

Andrew Clark

Managing Director

Kyra Doolan

Managing Director, Funds II, III and IV

Kevin King

Managing Director

Christy Luquire

Managing Director

Christina Luquire

Managing Director and Fund I Deal Committee Member

David Steakley

Managing Director

Rob Tucci

Managing Director

Bill Wheelock

Managing Director

Past deals in Texas

Dynamic Light

Convertible Note in 2022
Dynamic Light, founded in May 2018 and based in Austin, Texas, specializes in the development of innovative blood flow imaging technology. The company's mission is to enhance patient care and reduce healthcare costs through real-time, continuous, and quantitative visualization of blood flow in living tissues. Dynamic Light's technology allows surgeons to obtain high-resolution images of blood flow and perfusion without the need for dyes or procedural interruptions. This capability supports improved decision-making during surgical procedures, ultimately leading to better outcomes for patients.

Galen Data

Series A in 2021
Founded in 2016 and based in Houston, Texas, Galen Data offers a configurable, scalable software platform for medical devices. This platform securely collects, stores, visualizes, and analyzes data, enabling companies to focus on innovation without needing expertise in software design or cybersecurity.

Ikonopedia

Series D in 2021
Ikonopedia, LLC is a developer of a cloud-based breast study interpretation and reporting system designed to enhance the efficiency of radiologists. Established in 2012 and headquartered in Dallas, Texas, the company provides a comprehensive Mammography Reporting System that ensures compliance with the Mammography Quality Standards Act (MQSA) and offers customizable report macros for individual practitioners. Additionally, Ikonopedia's SonoPro application supports radiologists during diagnostic breast ultrasound exams. The solutions are designed to automate tracking and monitoring of patients, ensuring clear and consistent clinical reports that adhere to the ACR BI-RADS® Atlas 5th Edition. The system is compatible with various modern devices and is utilized by telemammography and satellite clinics, ultimately aiming to improve patient safety, streamline workflows, and enhance the overall experience for radiologists and their staff.

VenoStent

Seed Round in 2021
VenoStent develops bioabsorbable smart polymer wraps for vascular surgeries. Its flagship product, SelfWrap, is a perivascular wrap designed to reduce failures at the vein-artery junction in dialysis patients by promoting outward vein growth and providing custom-fit mechanical support. The company's technology acts as an external stent, reducing surgery time, infection risk, and wound reopening while improving vein usability and durability.

Allotrope Medical

Series A in 2021
Allotrope Medical Inc. is a Houston-based medical device company that specializes in manufacturing surgical devices aimed at enhancing surgical procedures. The company's flagship product, StimSite, is an intuitive handheld device designed specifically to assist surgeons in quickly and accurately identifying ureters during operations. This device not only aids in ureter localization but also functions as a blunt dissection tool, streamlining the surgical process. By employing a simple single-button design, Allotrope Medical's device eliminates the need for additional pre and post-operative procedures, thereby improving efficiency in pelvic surgeries. Established in 2016, the company focuses on innovative solutions that enhance surgical accuracy and patient safety.

Allotrope Medical

Convertible Note in 2020
Allotrope Medical Inc. is a Houston-based medical device company that specializes in manufacturing surgical devices aimed at enhancing surgical procedures. The company's flagship product, StimSite, is an intuitive handheld device designed specifically to assist surgeons in quickly and accurately identifying ureters during operations. This device not only aids in ureter localization but also functions as a blunt dissection tool, streamlining the surgical process. By employing a simple single-button design, Allotrope Medical's device eliminates the need for additional pre and post-operative procedures, thereby improving efficiency in pelvic surgeries. Established in 2016, the company focuses on innovative solutions that enhance surgical accuracy and patient safety.

VenoStent

Seed Round in 2020
VenoStent develops bioabsorbable smart polymer wraps for vascular surgeries. Its flagship product, SelfWrap, is a perivascular wrap designed to reduce failures at the vein-artery junction in dialysis patients by promoting outward vein growth and providing custom-fit mechanical support. The company's technology acts as an external stent, reducing surgery time, infection risk, and wound reopening while improving vein usability and durability.

Galen Data

Seed Round in 2019
Founded in 2016 and based in Houston, Texas, Galen Data offers a configurable, scalable software platform for medical devices. This platform securely collects, stores, visualizes, and analyzes data, enabling companies to focus on innovation without needing expertise in software design or cybersecurity.

Zibrio

Convertible Note in 2019
Zibrio specializes in advanced balance diagnostics. It leverages NASA technology originally used on astronauts, along with machine learning, to measure subtle changes in balance. Incorporated in 2017, Zibrio aims to empower users to manage their health proactively by providing insights into their balance profiles.

Allotrope Medical

Convertible Note in 2019
Allotrope Medical Inc. is a Houston-based medical device company that specializes in manufacturing surgical devices aimed at enhancing surgical procedures. The company's flagship product, StimSite, is an intuitive handheld device designed specifically to assist surgeons in quickly and accurately identifying ureters during operations. This device not only aids in ureter localization but also functions as a blunt dissection tool, streamlining the surgical process. By employing a simple single-button design, Allotrope Medical's device eliminates the need for additional pre and post-operative procedures, thereby improving efficiency in pelvic surgeries. Established in 2016, the company focuses on innovative solutions that enhance surgical accuracy and patient safety.

VenoStent

Pre Seed Round in 2019
VenoStent develops bioabsorbable smart polymer wraps for vascular surgeries. Its flagship product, SelfWrap, is a perivascular wrap designed to reduce failures at the vein-artery junction in dialysis patients by promoting outward vein growth and providing custom-fit mechanical support. The company's technology acts as an external stent, reducing surgery time, infection risk, and wound reopening while improving vein usability and durability.

Ikonopedia

Series C in 2019
Ikonopedia, LLC is a developer of a cloud-based breast study interpretation and reporting system designed to enhance the efficiency of radiologists. Established in 2012 and headquartered in Dallas, Texas, the company provides a comprehensive Mammography Reporting System that ensures compliance with the Mammography Quality Standards Act (MQSA) and offers customizable report macros for individual practitioners. Additionally, Ikonopedia's SonoPro application supports radiologists during diagnostic breast ultrasound exams. The solutions are designed to automate tracking and monitoring of patients, ensuring clear and consistent clinical reports that adhere to the ACR BI-RADS® Atlas 5th Edition. The system is compatible with various modern devices and is utilized by telemammography and satellite clinics, ultimately aiming to improve patient safety, streamline workflows, and enhance the overall experience for radiologists and their staff.

TeVido BioDevices

Venture Round in 2019
TeVido BioDevices, Inc. is a biotech start-up based in Austin, Texas, focused on developing innovative tissue-engineered products for reconstructive surgery. Established in 2016, the company utilizes a platform technology that integrates 3D bio-printing with patients' living cells to create custom grafts. These grafts specifically address unmet needs in reconstructive and cosmetic surgery, particularly for individuals who have lost skin color due to scarring or disease. TeVido's approach aims to enhance the quality of life and self-esteem of those affected by disfigurement while also having potential applications in wound healing and broader cosmetic procedures. Through its advanced manufacturing techniques and cellular therapy innovations, TeVido BioDevices is poised to significantly improve surgical outcomes in the field of reconstructive medicine.

ClearCam

Seed Round in 2018
ClearCam Inc. is a medical technology company based in Austin, Texas, founded in 2018. It specializes in developing innovative tools that enhance visibility for surgeons during laparoscopic procedures. The company's flagship product, the ClearCam Kelling, is a laparoscope lens cleaning device designed to maintain a clear visual field without necessitating the removal of the laparoscope from the surgical site. This device attaches directly to the scope and does not require additional supplies, thereby streamlining surgical processes, saving time, and improving overall safety for patients and medical staff alike.

TeVido BioDevices

Seed Round in 2018
TeVido BioDevices, Inc. is a biotech start-up based in Austin, Texas, focused on developing innovative tissue-engineered products for reconstructive surgery. Established in 2016, the company utilizes a platform technology that integrates 3D bio-printing with patients' living cells to create custom grafts. These grafts specifically address unmet needs in reconstructive and cosmetic surgery, particularly for individuals who have lost skin color due to scarring or disease. TeVido's approach aims to enhance the quality of life and self-esteem of those affected by disfigurement while also having potential applications in wound healing and broader cosmetic procedures. Through its advanced manufacturing techniques and cellular therapy innovations, TeVido BioDevices is poised to significantly improve surgical outcomes in the field of reconstructive medicine.

DNAtrix

Convertible Note in 2016
DNAtrix, Inc. is a clinical-stage biotechnology company based in Houston, Texas, with an additional office in San Diego, California. The company specializes in developing virus-driven immunotherapies for cancer treatment, focusing initially on glioblastoma, a highly aggressive and currently untreatable brain tumor. Its lead product, DNX-2401, is a modified oncolytic virus derived from a common cold virus, designed to selectively target and kill cancer cells. This innovative approach has shown promising results, with over 35 patients treated and positive early outcomes reported. In addition to DNX-2401, DNAtrix is advancing other candidates such as DNX-2440 and DNX-2450 for solid tumors, as well as MYX-135 for hematological malignancies. The company also has a strategic partnership with Valo Therapeutics, further enhancing its research and development capabilities in the field of cancer immunotherapy.

Infrastructure Networks

Venture Round in 2016
Infrastructure Networks provides services for the acquisition and delivery of natural energy resources required to power a modern economy. It eliminates the frustrations associated with managing and scaling remote communications by providing end-to-end customer connectivity solutions. By leveraging the global scale and adoption of a leading standards-compliant technology, recognized technology leaders, along with 24/7 monitoring and boots-on-ground service, INET delivers “Wireless Infrastructure-as-a-Service” (W-Iaas) over the industry’s first end-to-end, private, LTE network. The company was founded in 2011 and is based in Houston, Texas.

Adient Medical

Series C in 2016
Founded in 2012, Adient Medical specializes in developing absorbable medical devices. Its flagship product is an absorbable vascular filter designed for preventing pulmonary embolisms, aiming to enhance patient safety and reduce complications associated with traditional implants.

Adient Medical

Seed Round in 2015
Founded in 2012, Adient Medical specializes in developing absorbable medical devices. Its flagship product is an absorbable vascular filter designed for preventing pulmonary embolisms, aiming to enhance patient safety and reduce complications associated with traditional implants.

Set.fm

Convertible Note in 2015
Set.fm, Inc. is an Austin, Texas-based company that operates an innovative online platform enabling live concert performers to capture and sell their performances immediately after the event. Established in 2012 and formerly known as DejaSet, Inc., Set.fm provides musicians with a user-friendly mobile app that allows them to record high-quality audio of their live shows, often using equipment they already possess. This technology facilitates the promotion and sale of recordings, giving artists an opportunity to generate additional revenue streams. Fans can purchase recordings of performances they attended, enhancing their experience and allowing them to relive the event long after it has concluded. Set.fm aims to support musicians and enrich the live music experience for fans worldwide.

DNAtrix

Series B in 2014
DNAtrix, Inc. is a clinical-stage biotechnology company based in Houston, Texas, with an additional office in San Diego, California. The company specializes in developing virus-driven immunotherapies for cancer treatment, focusing initially on glioblastoma, a highly aggressive and currently untreatable brain tumor. Its lead product, DNX-2401, is a modified oncolytic virus derived from a common cold virus, designed to selectively target and kill cancer cells. This innovative approach has shown promising results, with over 35 patients treated and positive early outcomes reported. In addition to DNX-2401, DNAtrix is advancing other candidates such as DNX-2440 and DNX-2450 for solid tumors, as well as MYX-135 for hematological malignancies. The company also has a strategic partnership with Valo Therapeutics, further enhancing its research and development capabilities in the field of cancer immunotherapy.

Deep Imaging Technologies

Venture Round in 2014
Deep Imaging Technologies, Inc. is a subsurface imaging company established in 2008 and located in Tomball, Texas. The company specializes in developing advanced data collection equipment and software technologies tailored for the oil and gas industry. Its product offerings include surface imaging systems that utilize electromagnetic fields generated at very low frequencies to effectively image geological features. The combination of transmitters, receivers, and imaging software positions Deep Imaging Technologies as a key player in enhancing subsurface data acquisition and interpretation within the sector.

Cinegif

Seed Round in 2013
Cinegif is an Austin-based software company that specializes in patented video conversion technology. It helps marketing professionals create engaging animated GIFs from still images and videos for web pages, emails, social media, texts, and digital signage.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.